Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06179498 · ClinicalTrials.gov registry record · NA

Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs

A NA study of Hepatitis C, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT06179498 is a NA study of Hepatitis C that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 500 participants, below the 1,885-participant average among 106 other Hepatitis C trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06179498, a NA study of Hepatitis C, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The Partner Navigation Intervention Study is a randomized controlled study (RCT) to assess the efficacy and mechanism of action of the first behavioral intervention to increase hepatitis C (HCV) treatment initiation among adult people who inject drugs (PWID).

Conditions Studied

Interventions

  • BEHAVIORAL Partner Navigation Intervention

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-03-25
Est. Completion 2027-06-01
Phase NA

What the Registry Record Tells You About NCT06179498

The ClinicalTrials.gov registry entry for NCT06179498 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,885-participant average among 106 other Hepatitis C trials with a reported enrollment target (73% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which Partner Navigation Intervention is the first listed.

NCT06179498 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06179498 about?

NCT06179498 is a clinical study titled "Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs". The Partner Navigation Intervention Study is a randomized controlled study (RCT) to assess the efficacy and mechanism of action of the first behavioral intervention to increase hepatitis C (HCV) treatment initiation among adult people who inject drugs (PWID).

What is the current status of trial NCT06179498?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2024-03-25. Estimated completion is 2027-06-01.

What conditions does trial NCT06179498 study?

This clinical trial studies the following conditions: Hepatitis C.

What interventions are being tested in trial NCT06179498?

The interventions under investigation include: Partner Navigation Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06179498?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06179498 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.